Atrial Septal Defects
Conditions
Interventions
Observation group:None
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >=18 years; 2. Diagnosed primarily with ASD, without other complex congenital heart defects such as atrioventricular septal defect (AVSD), Tetralogy of Fallot (ToF), transposition of the great arteries (TGA), right ventricular outflow tract obstruction (RVOTO), etc.; 3. Underwent ASD closure/repair surgery without MR surgery, including patients who had concurrent tricuspid valve surgery or maze procedure; 4. Have complete preoperative clinical data and echocardiographic data; 5. Have at least one postoperative follow-up echocardiography.
Exclusion criteria
Exclusion criteria: 1. Presence of organic mitral valve disease before surgery (such as rheumatic, degenerative, infective endocarditis, chordal rupture, etc.); 2. Combined with other major cardiac surgeries that need to be performed simultaneously (such as coronary artery bypass grafting, aortic valve replacement, etc.); 3. History of previous mitral valve surgery; 4. Missing follow-up data or lost to follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| aggravation of mitral regurgitation ;mortality; | — |
Secondary
| Measure | Time frame |
|---|---|
| mitral valve reoperation;residual shunt;aggravation of tricuspid regurgitation ;reoperation; | — |
Countries
China
Contacts
Public ContactChangping Gan
West China Hospital of Sichuan University
Outcome results
None listed